Science Explorer Back to mapMap
Discussion
Hospital / health system · Santa Monica · United States

Sarcoma Oncology Center

In research, Sarcoma Oncology Center stands highest in Health Sciences (#10,085 of 16,688 worldwide) and Medicine (#9,228 of 14,558 worldwide), over all time.

sarcomaoncology.comROR OpenAlex
World rank, all time
#30,837
of 34,923
Rank in United States
#6,513
of 7,310
Research works
303
▲ 53% vs 2018-21
Citations
9.7k
32.2 per fractional work
Top-10% rate
7.9%
all institutions 10.0%
vs its own fields
1.02×
1.00× is exactly expected
Open access
24%
world 40%
International
23%
world 18%
Sarcoma Oncology Center

What is Sarcoma Oncology Center known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #10,085 of 16,688 17.5%227
MedicineField #9,228 of 14,558 17.1%223

Each strip is that field's whole ranked pool, with the notch where Sarcoma Oncology Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Sarcoma Oncology Center work in?

In 2022-now, 80% of research at Sarcoma Oncology Center is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (77%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (4%). It does 3.0× the world's share of Health Sciences.

Health Sciences: 48 fractional works · 79.7% of its workMedicine: 46 fractional works · 77.2% of its workOncology: 14 fractional works · 24.0% of its workPulmonary and Respiratory Medicine: 10 fractional works · 16.1% of its workSurgery: 6 fractional works · 10.5% of its workPhysiology: 4 fractional works · 6.3% of its workPathology and Forensic Medicine: 2 fractional works · 4.1% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 2.8% of its workGastroenterology: 1 fractional works · 2.1% of its workOtorhinolaryngology: 1 fractional works · 2.1% of its workRheumatology: 1 fractional works · 1.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.7% of its workNeurology: 1 fractional works · 1.1% of its workEpidemiology: 1 fractional works · 0.9% of its workDermatology: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.6% of its workDentistry: 1 fractional works · 2.0% of its workOral Surgery: 1 fractional works · 1.5% of its workPeriodontics: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workLife Sciences: 10 fractional works · 16.8% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 12.3% of its workMolecular Biology: 3 fractional works · 4.6% of its workBiotechnology: 3 fractional works · 4.4% of its workCancer Research: 1 fractional works · 1.7% of its workGenetics: 1 fractional works · 1.6% of its workImmunology and Microbiology: 2 fractional works · 3.6% of its workImmunology: 2 fractional works · 3.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.6% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 2.0% of its workEngineering: 0 fractional works · 0.7% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workChemistry: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.2% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 1.5% of its workSocial Sciences: 1 fractional works · 1.3% of its workSociology and Political Science: 0 fractional works · 0.7% of its workHealth: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKSarcoma OncologyCenter60fractional works, 2022-now
Life Sciences17%Physical Sciences2%Health Sciences80%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine4677.2%
    2. Dentistry12.0%
    3. Health Professions00.5%
    1. Biochemistry, Genetics and Molecular Biology712.3%
    2. Immunology and Microbiology23.6%
    3. Neuroscience10.9%
    4. Agricultural and Biological Sciences00.1%
    1. Engineering00.7%
    2. Materials Science00.6%
    3. Chemistry00.4%
    4. Computer Science00.2%
    5. Environmental Science00.1%
    1. Social Sciences11.3%
    2. Economics, Econometrics and Finance00.1%
    3. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.01× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.30× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 3.58× its world share, 2 worksImmunology and Micro…Neuroscience: 0.56× its world share, 0 worksNeuroscienceChemistry: 0.27× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.17× its world share, 0 worksMaterials ScienceDentistry: 4.19× its world share, 1 worksDentistryHealth Professions: 0.20× its world share, 0 worksHealth ProfessionsMedicine: 4.01× its world share, 46 worksMedicineEconomics, Econometrics and Finance: 0.05× its world share, 0 worksEconomics, Econometr…Psychology: 0.02× its world share, 0 worksPsychologySocial Sciences: 0.10× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 4.2×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Dentistry4.19×1 works
  2. Medicine4.01×46 works
  3. Immunology and Microbiology3.58×2 works
  4. Biochemistry, Genetics and Molecular Biology2.30×7 works
  5. Neuroscience0.56×0 works
  6. Chemistry0.27×0 works
  7. Health Professions0.20×0 works
  8. Materials Science0.17×0 works
  9. Social Sciences0.10×1 works
  10. Engineering0.05×0 works
  11. Economics, Econometrics and Finance0.05×0 works
  12. Computer Science0.02×0 works
  13. Psychology0.02×0 works
  14. Agricultural and Biological Sciences0.01×0 works
  15. Environmental Science0.01×0 works

Who are the top researchers at Sarcoma Oncology Center?

Ranked on the quality score, Sant P. Chawla, Kamalesh Kumar Sankhala and Victoria S. Chua-Alcala lead among researchers whose main affiliation is Sarcoma Oncology Center.

  1. 1 Sant P. Chawla United States · #52,268 worldwide 20k citations · 565 works
  2. 2 Kamalesh Kumar Sankhala United States · #1,262,662 worldwide 2.4k citations · 142 works
  3. 3 Victoria S. Chua-Alcala United States · #2,796,562 worldwide 144 citations · 27 works
  4. 4 Ania M. Moradkhani United States · #3,488,483 worldwide 142 citations · 31 works
  5. 5 Don Arlen Brigham United States · #3,579,540 worldwide 97 citations · 20 works
  6. 6 Victoria S. Chua United States · #4,039,223 worldwide 307 citations · 72 works
  7. 7 Samantha Jeffrey United States · #4,455,497 worldwide 8 citations · 21 works
  8. 8 Doris M Quon United States · #4,610,916 worldwide 43 citations · 17 works
  9. 9 Erlinda Maria Gordon United States · #5,002,594 worldwide 4k citations · 199 works
  10. 10 Nataliya Omelchenko United States · #5,642,216 worldwide 146 citations · 18 works
All ranked researchers at Sarcoma Oncology Center

What are the most cited papers from Sarcoma Oncology Center?

The most cited paper from Sarcoma Oncology Center is "Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial" (Winette T.A. van der Graaf et al., 2012), with 2,123 citations. Next come "Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials" (1,802) and "Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial" (782).

Most cited papers
#PaperReleasedCitations
1 Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial Winette T.A. van der Graaf et al. · The Lancet Open access May 2012 2,123
2 Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials Robert Charles Doebele et al. · The Lancet Oncology Open access 11 Dec 2019 1,802
3 Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial Patrick Schöffski, Sant P. Chawla, Robert G. Maki et al. · The Lancet Open access 12 Feb 2016 782
4 Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion Sewa S. Legha, Robert S. Benjamin, Bruce R. MacKay et al. · Annals of Internal Medicine Feb 1982 769
5 Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study David Morgan Thomas, Robert Mikael Henshaw, Keith M. Skubitz et al. · The Lancet Oncology 11 Feb 2010 716
All 60 most cited papers, with filters and sorting

Which keywords describe research at Sarcoma Oncology Center?

By fractional works in 2022-now, weighted toward what it does more of than the world: Prognostic Factors, Chemotherapy, Lymphoma, Immunotherapy, Tumor Regression, Clinical Practice Guidelines, Osteosarcoma and Soft Tissue Sarcoma.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors15▲ 57×9 topics
  2. Chemotherapy12▲ 29×13 topics
  3. Lymphoma12▲ 121×3 topics
  4. Immunotherapy11▲ 25×11 topics
  5. Clinical Practice Guidelines9▲ 26×4 topics
  6. Tumor Regression9▲ 131×2 topics
  7. Osteosarcoma8▲ 299×1 topic
  8. Soft Tissue Sarcoma8▲ 263×1 topic
  9. Cancer Immunotherapy7▲ 79×3 topics
  10. CAR T Cells6▲ 148×1 topic
  11. Chimeric Antigen Receptor6▲ 148×1 topic
  12. Radiotherapy6▲ 26×9 topics
  13. Molecular Classification5▲ 55×3 topics
  14. Inflammation4▲ 3.4×12 topics
  15. Adenoid Cystic Carcinoma4▲ 269×1 topic
  16. Diagnostic Criteria4▲ 28×3 topics
  17. PET Imaging4▲ 38×4 topics
  18. Salivary Gland Tumors4▲ 269×1 topic
  19. Biomarkers4▲ 8.9×4 topics
  20. Treatment3▲ 4.6×3 topics
  21. Gene Therapy3▲ 28×3 topics
  22. Autoimmune Disease3▲ 84×1 topic
  23. Rheumatology3▲ 138×2 topics
  24. Saliva3▲ 215×1 topic
  25. Tumor Microenvironment3▲ 11×6 topics
  26. Tumor Targeting3▲ 27×3 topics
  27. Genetic Mutations3▲ 10×9 topics
  28. Surgical Management2▲ 10.0×6 topics
  29. Arginine Deprivation2▲ 98×1 topic
  30. Bacterial Therapy2▲ 98×1 topic
  31. Cancer2▲ 2.8×15 topics
  32. Immune Checkpoint Blockade2▲ 31×1 topic
  33. Molecular Profiling2▲ 37×2 topics
  34. PD-1 and PD-L12▲ 31×1 topic
  35. Classification2▲ 7.5×1 topic
  36. Rituximab2▲ 24×1 topic
  37. Angiosarcoma2▲ 201×1 topic
  38. Cetuximab2▲ 32×2 topics
  39. Epithelioid Hemangioendothelioma2▲ 201×1 topic
  40. Prognosis1▲ 7.3×2 topics

Which research topics does Sarcoma Oncology Center publish most on?

By volume in 2022-now: Sarcoma Diagnosis and Treatment, CAR-T cell therapy research, Salivary Gland Tumors Diagnosis and Treatment and Salivary Gland Disorders and Functions.

Sarcoma Diagnosis and Tr…8Sarcoma Diagnosis and Treatment: 8 fractional worksCAR-T cell therapy research: 6 fractional worksSalivary Gland Tumors Diagnosis and Treatment: 4 fractional worksSalivary Gland Disorders and Functions: 3 fractional worksCancer Research and Treatments: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksLymphoma Diagnosis and Treatment: 2 fractional worksVascular Tumors and Angiosarcomas: 2 fractional worksGastrointestinal Tumor Research and Treatment: 1 fractional worksHead and Neck Cancer Studies: 1 fractional works
Pulmonary and Respiratory MedicineOncologySurgeryPhysiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 8 works
  2. 2 CAR-T cell therapy research Oncology 6 works
  3. 3 Salivary Gland Tumors Diagnosis and Treatment Surgery 4 works
  4. 4 Salivary Gland Disorders and Functions Physiology 3 works
  5. 5 Cancer Research and Treatments Biotechnology 2 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 2 works
  7. 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  8. 8 Vascular Tumors and Angiosarcomas Oncology 2 works
  9. 9 Gastrointestinal Tumor Research and Treatment Gastroenterology 1 works
  10. 10 Head and Neck Cancer Studies Otorhinolaryngology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.4%not open75.6%

World: 40% of research is openly available.

with international co-authors22.7%domestic only77.3%

World: 18% is written across borders.

How has Sarcoma Oncology Center's research output changed?

Output in 2022-2025 was 53% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sarcoma Oncology Center as a percentage of every work published that year, 0.00019% in 2024.

still counting0.0020%0.0040%Sarcoma Oncology Center0.00041% in 202519801990200020102020

Fractional works of Sarcoma Oncology Center over all fractional works that year. How the balance of science has shifted.

Other research institutions in Santa Monica

All research institutions in Santa Monica

Share Sarcoma Oncology Center's ranking

Sarcoma Oncology Center on Science Explorer

A card with Sarcoma Oncology Center's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sarcoma Oncology Center. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.